JRJosé Manuel Ortiz de la Rosa

José Manuel Ortiz de la Rosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


José Manuel Ortiz de la Rosa has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AmpCENTA: a rapid assay for detecting AmpC-hyperproduction in Enterobacter cloacae complex and Klebsiella aerogenes

    by Paula Gómez Estévez, Marta Rodríguez-Rodríguez, Javier Dorado Pardo, Pilar Durán Parejo, José Miguel Cisneros, José Manuel Ortiz de la Rosa, José Antonio Lepe, Ángel Rodríguez-Villodres

  • Open Access

    Characterization of BAS-1, a novel class A β-lactamase encoded in Bacteroides thetaiotaomicron

    by María Aznar Fernández, María José Gómez Gómez, José Miguel Cisneros, José Antonio Lepe, José Manuel Ortiz de la Rosa

    We characterized a novel class A β-lactamase (BAS-1) in a pan-β-lactam-resistant Bacteroides thetaiotaomicron clinical isolate. Whole-genome sequencing identified bla BAS-1 within a mobile genetic element associated with IS 4351 . Cloning, susceptibility testing, β-lactam inactivation method, and half-maximal inhibitory concentration assay confirmed resistance to penicillins, cephalosporins, monobactams, and reduced susceptibility to the β-lactamase inhibitors. To date, no class A β-lactamase from Bacteroides has been shown to display such a resistant profile, challenging the assumed reliability of β-lactam/β-lactamase inhibitor combinations.

  • Essential role of the leucine-293 for the AmpC β-lactamase in the resistance to cefepime, cefiderocol, and new β-lactams/β-lactamase inhibitor combinations in Enterobacter hormaechei

    by Marta Rodríguez-Rodríguez, Enrique Alanís-Domínguez, Carlos S. Casimiro-Soriguer, José Manuel Ortiz de la Rosa, Carmen Soto-Gallego, Javier Dorado Pardo, Ana María Rojas, José Antonio Lepe, Ángel Rodríguez-Villodres

  • Novel KPC-2 Plasmid in a Clinical Salmonella Rissen Selected by Antibiotic Pressure

    by María Aznar Fernández, Ángel Rodríguez-Villodres, María José Gómez-Gómez, José Miguel Cisneros, José Manuel Ortiz de la Rosa, José Antonio Lepe

    In this work, we present the genomic characterization of a clinical Salmonella enterica serovar Rissen isolate harboring a novel IncN2 plasmid carrying the blaKPC-2 gene. The identified plasmid (pSEay-KPC) also encoded additional resistance genes, including blaACC-1, blaTEM-1, and qnrB. The pSEay-KPC conferred broad-spectrum antimicrobial resistance, allowing the pathogen to survive two consecutive antibiotic therapies with ceftriaxone and ciprofloxacin. Effective treatment was ultimately achieved with meropenem–vaborbactam, a last-resort agent. These findings highlight IncN2 plasmids as potent vectors for the spread of clinically significant resistance genes, enabling bacteria to evade frontline antimicrobials and complicating infection management.


  • Open Access

    KSA-1, a naturally occurring Ambler class A extended spectrum β-lactamase from the enterobacterial species Kosakonia sacchari

    by Claudine Fournier, Patrice Nordmann, Jose-Manuel Ortìz de la Rosa, Ayda Kusaksizoglu, Laurent Poirel


  • Open Access

    MDR Shigella sonnei in Spain: an ever-evolving emerging threat?

    by José Manuel Ortiz de la Rosa, Ángel Rodríguez-Villodres, Carlos S Casimiro-Soriguer, Maite Ruiz-Pérez De Pipaón, Eduardo Briones, María Aznar Fernández, José Antonio Lepe

    Seven CTX-M-27-producing Shigella sonnei strains were isolated at the University Hospital Virgen del Rocío (Seville, Spain) microbiology service from October to November 2021. To offer extensive information on the microbiological and molecular epidemiology results of the seven S. sonnei isolates and compare them with other previously documented CTX-M-27-producing S. sonnei associated with MSM transmission. S. sonnei isolated from stool samples of patients with acute diarrhoea were identified through biochemical and serological typing. Whole characterization of the seven isolates was performed by sequencing with MinION Mk1C followed by genomic and molecular analysis. All the isolates were resistant to penicillins, cephalosporins, fluoroquinolones, cotrimoxazole and azithromycin. Sequencing showed the presence of several resistance determinants, outstanding blaCTX-M-27, azithromycin resistance genes [ermB and mph(A)], qnrB19 and mutations in the QRDRs. All isolates belonged to the same hierarchical clustering of cgMLST (HierCC) with five allele distance (HC5) scheme v1 from EnteroBase. However, they presented differences in plasmid composition, with all seven isolates harbouring IncFII, IncB/O/K/Z and ColE1-like while SH2, SH6 and SH7 had IncFIB only. Our isolates were closely related to others from Spain (HC5; 98748), Australia (HC5; 98748) and the UK (HC5; 98748), which were also associated with MSM transmission. Nevertheless, the structure of the non-chromosomal genetic elements and the genetic context of blaCTX-M-27 presented a certain variability compared with isolates from other countries and among them. This study confirms the emergence of CTX-M-27-producing S. sonnei (ST152) associated with MSM transmission in Spain, adding it to the Europe outbreak list and reinforcing the necessity of active surveillance and control of this high-risk clone.


  • Open Access

    Genomic Features of MCR-1 and Extended-Spectrum β-Lactamase-Producing Enterobacterales from Retail Raw Chicken in Egypt

    by Mustafa Sadek, José Manuel Ortiz de la Rosa, Mohamed Abdelfattah Maky, Mohamed Korashe Dandrawy, Patrice Nordmann, Laurent Poirel

    Colistin is considered as a last resort agent for treatment of severe infections caused by carbapenem-resistant Enterobacterales (CRE). Recently, plasmid-mediated colistin resistance genes (mcr type) have been reported, mainly corresponding to mcr-1 producers. Those mcr-1-positive Enterobacterales have been identified not only from human isolates, but also from food samples, from animal specimens and from environmental samples in various parts of the world. Our study focused on the occurrence and characterization of mcr-1-positive Enterobacterales recovered from retail raw chicken in Egypt. From the 345 retail chicken carcasses collected, a total of 20 samples allowed to recover mcr-1-positive isolates (Escherichia coli, n = 19; Citrobacter freundii, n = 1). No mcr-2- to mcr-10-positive isolate was identified from those samples. The colistin resistance trait was confirmed for all those 20 isolates with a positivity of the Rapid Polymyxin NP (Nordmann-Poirel) test. Minimum inhibitory concentrations (MICs) of colistin for all MCR-1-producing isolates ranged between 4 and 16 μg/mL. Noticeably, 9 out of the 20 mcr-1-positive isolates produced an extended-spectrum β-lactamase (ESBL), respectively producing CTX-M-9 (n = 2), CTX-M-14 (n = 4), CTX-M-15 (n = 2), and SHV-12 (n = 1). Noteworthy, the fosA4 gene encoding resistance to fosfomycin was found in a single mcr-1-positive E. coli isolate, in which both genes were located on different conjugative plasmids. The pulsed-field gel electrophoresis (PFGE) patterns were identified, corresponding to 10 different sequence types (STs), highlighting the genetic diversity of those different E. coli. Whole-genome sequencing revealed three major types of mcr-1-bearing plasmids, corresponding to IncI2, IncX4, and IncHI2 scaffolds. The occurrence of MCR-1-producing multidrug-resistant Enterobacterales in retail raw chicken is of great concern, considering the possibility of transmission to humans through the food chain.